A randomized controlled trial to evaluate the effectiveness of insoles to treat plantar heel pain

SSL International (UK)0 个研究点目标入组 150 人开始时间: 2008年7月31日最近更新: 2016年10月17日

试验速览

暂无简介。

•1. Male or female participants between the ages of 18 and 65 years old
•2. Participants with self-reported plantar heel pain with a minimum of 4 weeks duration
•3. Self-reported plantar heel pain who score at least 40 mm on a 100 mm visual analogue scale (VAS) for pain
•4. Participants with plantar heel pain in the 2 days prior to recruitment
•5. Participants who agree to wear the insoles provided for at least 4 hours each day
•6. Participants who give written informed consent

•1. Participants reporting acute injury to the foot at the onset of the plantar heel pain
•2. Participants with posterior or medial/lateral heel pain or any secondary pain elsewhere in the foot since the onset of plantar heel pain
•3. Participants with significant musculo-skeletal disease diagnosed such as rheumatoid arthritis, hip, knee or back pain
•4. Participants with sensory or motor function disease such as diabetes
•5. Participants who are pregnant or breast-feeding
•6. Participants who have received or self-administered treatment for the heel pain in the previous 4 weeks
•7. Participants who have received corticosteroid injection therapy in the heel in the previous 3 months
•8. Participants that were previously in this study
•9. Participants that were in another study within the last 3 months

发起方

SSL International (UK)